Abstract

TREATMENT OF COVID-19 BY STUDYING AND OBSERVING PRESCRIPTION-BASED MEDICATION IN A PATIENT REPORTED WITH COVID, SARS-COV CASE, AN ACTUAL PRACTICE IN PHARMACY AND, THE HOSPITALS. A CASE STUDY REPORT

*Dr. Saurabh Dilip Bhandare, Tajane Omkar Prakash, Valvi Snehal Ravindra and Sonal Devidas Nerkar

.

Abstract

COVID-19 is caused by a venurable SARS-CoV group of viruses that cause severe to acute respiratory diseases in vulnerable people or the patients diagnosed with it. The cure and treatment were critical at the initial and there were many critical cases reported to be diagnosed with COVID positive. The death of patients were high due to unavailability of medication and proper treatment. Newer medications such as: Remdesiver, Favipiravir antiviral drugs, Lopinavir- Ritonavir treatment were also had been a part of trial. This study investigated a diagnosis report of a patient based on patients consent to study and reproduce the diagnosis for study and information purposes. Studying medication in current medication practices in the health care systems are very important, so the conduct of this case study was obtained to meet the understanding of current medicinal practices and, the effect of some of the medication on the patient. Understanding the recovery state, and concern of pharmacovigilance, in the in the health care is majour concern of this case report. But there are currently no proven ways to stop the spread of this lethal virus. SARS-CoV-II. Scientists are working really hard to develop efficient mitigation strategies while also studying the mechanisms of virus transmission, along with the medication.

Keywords: SARS-CoV treatment, case report, studying pharmacovigilance data, patient case study report, pharmacovigilance safety data.